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ABSTRACT Eight 15N-Iabeled nonessential amino acids plus l sNH~CI were ad-
ministered over a 10-h period to four healthy adult males using a primed-constant dosage 
regimen. The amount of 15N excreted in the urine and the urinary ammonia, hippuric 
acid and plasma alanine 15N enrichments were measured. There was a high degree of 
consistency across subjects in the ordering of the nine compounds based on the frac-
tion of lsN excreted (Kendall coefficient of concordance W=0.83, 'P < 0.01) . Protein 
synthesis rates were calculated from the urinary ammonia plateau enrichment and 
the cumulative excretion of 15N. Glycine was one of the few amino acids that gave 
similar values by both methods. J. Nutr. 116: 1651-1659, 1986. 
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We are interested in the use of 15N-Iabeled 
glycine as a tracer for determining the hu-
man whole-body protein synthesis rate. 
There are several variants, the principal 
ones being 1) methods based on the enrich-
ment of the urinary ammonia (1,2), 2) decay 
curve analyses based on the decay of isotope 
enrichment in the urine or plasma following 
a single pulse, (3-5),3) from the cumulative 
excretion 15N excreted (6-8) and 4) a primed 
constant infusion-flux method (9). 
Although several other methods involving 
13C-Iabeled amino acids have been described, 
the methods using 15N are particularly suit-
able fo r use outside a hospital or clinical 
research center. The principal advantages of 
15N are: 1) 15N can be used for single dosage-
single sampling point methods, 2) serial sam-
pling is not required and 3) there is no need 
to collect and analyze exhaled breath. 
Although other 15N-Iabeled amino acids have 
nonessential amino acids protein 
been used, for example, alanine (10), aspar-
tate (11) and lysine (9, 12), glycine is the most 
frequently used 15N-Iabeled amino acid be-
cause of its availability and relatively low 
price (13). 
This study was designed to determine 
whether any of the other nonessential amino 
acids labeled with 15N offer any advantages 
over glycine. We compared the glycine-
based protein synthesis rates (PSR) using 
both the urinary ammonia plateau, 15N 
enrichment and a cumulative excretion 
method against those found with other 15N_ 
labeled nonessential amino acids. We also 
compared the relative effectiveness of glycine 
in transferring 15N to plasma alanine, urinary 
ammonia and urinary hippuric acid . 
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MATERIALS AND METHODS 
The subject population consisted of four 
healthy adult males between 27 and 42 years 
of age. Informed consent was obtained in 
accordance with the policies of the Gradu-
ate Hospital and the University of Pennsyl-
vania, Philadelphia, PA. 
Eight 15N-Iabeled nonessential L-amino 
acids plus [15N]ammonium chloride were 
tested. [15N]glycine (99 %) and arginine 
(96 %) were obtained from US Services/ 
ICONS, Summit, NJ; [15N]alanine (99 %); 
J5NH4CI (99 %) and [15N]glutamic acid 
(99 %) from KOR Isotopes, Inc. (now ICN), 
Cam bridge, MA; [lSN]aspartic acid (98 % ), 
[15N]serine (99 %) and [15N]amido-labeled 
asparagine (99 %) from Merck and Co., St. 
Louis, MO. and [15N]amido-labeled gluta-
mine (99 %) from Cambridge Isotopes, Inc., 
Cambridge, MA. Chemical and isotopic pu-
rity were verified by gas chromatograph-
mass spectrometry (GC-MS). The amino 
acids were converted to their N-acetyl 
isopropyl derivatives, and the spectra were 
compared with the appropriate spectra 
from unlabeled compounds. 
The total dose of 15N ranged between 20 
and 100 mg 15N per subject. For the more ex-
pensive amino acids, the first subject took 
between 35 and 70 mg lsN. The results were 
then analyzed and a decision made as to the 
minimum amount needed to give accurate 
data, and that dose was given to subsequent 
subjects. The reason for doing so was to 
minimize the cost of the study. The total 
dose (20-100 mg J5N) was divided into 13 
equal aliquots and placed in gelatin cap-
sules. Each capsule also contained 300 mg of 
sodium benzoate. Glycine is conjugated 
with benzoic acid in the liver to give hip-
puric acid, which is excreted in the urine. 
Thus the urinary hippuric acid provides a 
means of sampling the hepatic glycine pool 
(14). 
The nine 15N-Iabeled compounds were 
given in random order at approximately one 
per month to the four subjects. The study 
was started at 0700, after an overnight fast, 
with the subject voiding and taking a prim-
ing dose of four capsules. The remaining nine 
capsules were taken at hourly intervals 
thereafter. Each time the subject took a cap-
sule he drank 50 mL of Ensure (Ross 
Laboratories, Columbus, OH). Ensure is a 
defined formula diet containing 1 kcal/mL. 
The 50 kcal/h of Ensure was given because 
this caloric intake (500 kcal/l0 h) approxi-
mated the subjects' normal caloric intake 
for the period 700 to 1700. Subjects were per-
mitted to consume noncaloric beverages 
(water, coffee or tea but with no cream or 
sugar) and nothing else from 0700 to 1700. 
At 1700, 7.0 mL of blood was drawn. Sub-
jects collected a pooled urine for the period 
0700 to 1230, after which time urine was col-
lected approximately hourly until 1700. Dur-
ing the 10 h of the study the subjects 
performed their normal duties, which con-
sisted of a combination of laboratory and 
office work. 
Analytical methodology. Two methods 
were used for J5N analysis. Plasma alanine 
enrichments were determined by GC-MS, 
and optical emission spectroscopy was used 
for the urinary nitrogen, ammonia and hip-
puric acid and the plasma urea. The sensi-
tivity of the GC-MS and optical emission 
methods are ±0.2 and ±O.02 atom percent 
excess, respectively, in the range studied. 
Optical emission is the simpler technique, 
but requires a larger sample (3 p.g of N2) 
than the GC-MS method. Briefly, optical 
emission spectroscopy involves the irradia-
tion of N2 gas in a sealed 6-mm Vycor glass 
tube (Corning, Inc., Corning, NY) at 3 
mmHg pressure with radio frequency 
energy. The N2 molecules absorb the energy 
and reemit some of it as mauve light. The 
intensities of the emitted light at 297.68 nm 
(HN2) and 298.29 nm C5N14N) are compared 
by a standard monochromator-photomulti-
plier arrangement. This method requires that 
all samples be converted to N2 gas, and this 
is usually accomplished by conversion to am-
monia first and then oxidation to N2 by alka-
line hypobromite (15). 
The blood urea nitrogen (BUN) was de-
termined by the urease method using Sigma 
diagnostic kit #640 (Sigma Chemical Co., 
St. Louis, MO). For determination of the 
isotopic enrichment of the BUN, water (1 
mL) and urease solution (2.0 mL, 0.21 mg 
urease/mL in 0.1 M phosphate buffer, pH 
6.5) was added to plasma (2.0 mL). After in-
cubating for 3D min at 37°C, K2C03 (5 mL) 
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and 2-octanol (8 drops) were added. The 
ammonia was removed by aeration and col-
lected in 0.1 N H2S04 (1 mL). Total urinary 
nitrogen was measured on 1 mL of urine by 
the Kjeldahl method. Urinary ammonia was 
isolated from urine (5 mL) by adding satu-
rated K2C03 (5 mL) and aerating was done 
as described above for the BUN. The ISN en-
richment of the urinary ammonia, total uri-
nary nitrogen for each void (Kjeldahl distil-
lates) and ammonia from the urease 
reaction on the BUN were determined by 
optical emission spectroscopy as previously 
described (15, 16). 
Hippuric acid was isolated from the urine 
by crystallization after adj usting the urine 
concentration to 30 % with sodium chloride 
(16). Occasionally the hippuric acid did not 
crystallize out. For those samples the urine 
(5 mL) was adjusted to pH 1 with concentra-
tion. H2S04 and the urine extracted three 
times with ether (5 mL). The ether extracts 
were combined and evaporated to dryness. 
The pale straw residues from either the salt 
precipitation or the ether extractions were 
dissolved in minimal hot water. On cooling 
at 4°C, white needle-shaped crystals of hip-
puric acid separated out. The hippuric acid 
was then converted to (NH4hS04 by Kjel-
dahl oxidation and analyzed for lsN by opti-
cal emission spectroscopy as described above. 
The enrichment of the plasma alanine 
was determined by converting the plasma 
amino acids to their N-acetyl isopropyl es-
ters as previously described (15). GC-MS 
analysis was done on a Hewlett-Packard 
5992A GC-MS in the selective ion monitor-
ing mode (SIM, ref. 15). The fragments at 
186 amu (atomic mass units) and 187 amu 
were monitored. The parent peak is at 186 
amu. 
Methods of calculation. Fraction of ISN ex-
creted. The amount of the administered dose 
excreted (*e) was calculated by summing the 
ISN excreted in each urine sample collected 
over the 10-h period and the ISN remaining 
in the body urea pool at 10 h. The latter was 
calculated from the blood taken at the end 
of the experiment. The size of body urea pool 
(in grams) was estimated from the BUN (in 
milligrams/lOO mL) using an equation der-
ived by Hume and Weyers (17): 
urea pool = UDS x 102 x BUN 
where UDS is urea distribution space and 
UDS = (0.195 x ht in centimeters) + (0.297 
x wt in kilograms) - 14.013. Thus ISN in 
urea pool = UDS (in liters) x BUN (in 
grams/liter) x BUN lsN (atom percent ex-
cess) x 0.01. 
Whole-body protein synthesis rates. The 
whole-body protein synthesis rate (PSR) was 
calculated from the urinary ammonia lsN 
enrichment at plateau (18) and from the to-
tal amount of lsN excreted (6-8). From the 
urinary ammonia, PSR was calculated as 
follows: 
Q = *d/A and Q = E + S 
where Q is nitrogen flux in grams N/hour; 
*d is rate of ISN glycine administration in 
grams N/hour; A is lsN abundance in the 
urinary ammonia at plateau (APE'O .OI); 
E is rate of N excretion in grams N/hour; S 
is rate of protein synthesis in grams N/hour; 
and APE is atom percent excess lsN. 
From the total lsN excreted (cumulative ex-
cretion), PSR was calculated as: 
S = ET.(*d/*e-l) 
where • d is amount of lsN given in grams N 
10/hour; • e is amount of 15N excreted (urine 
+ BUN) in grams N lO/hour; ET is amount 
of N excretion in grams N 10/hour; and S is 
rate of protein synthesis in grams N lO/hour . 
The total amount of 15N excreted (* e) was 
defined as described above. In this study, we 
assumed that there was no change in the 
BUN durin¥ the course of the study, and the 
amount of sN in the tissue free amino acid 
pools at 10 h was negligible (5, 19) . 
RESULTS 
A one-way, repeated-measures design 
analysis of variance was run on each meas-· 
ure: 1) % of 15N excreted, 2) PSR by a cu-
mulative excretion method, 3) PSR from the 
urinary ammonia 15N plateau, 4) urinary 
NH3 lsN enrichment at plateau, 5) plasma 
alanine ISN enrichment and 6) the urinary 
hippuric acid 15N enrichment. The results 
are summarized in figure 1 and table 1. The 
Kendall coefficient of concordance (W) was 
determined for each of the above measure-
ments to provide a measure of the degree of 
consistency across subjects ("intersubject 
reliability") for the amino acids (table 1, ref. 
~-- --~ - - - - -- - - - -~ - - ~ - -- - -- - - - ---
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Fig. 1 Percentage of '5N excreted from various nonessential amino acids. Data is mean ± SEM, n = 4. 
Numbers between groups are P-values. 
20). The major findings of this study were: 
1) There were significant differences in the 
fraction of 15N excreted among the various 
amino acids. The nonessential nitrogen 
compounds studied appeared to fall into 
five well-defined groups (figure 1). 
2) There was high intersubject reliability 
in the ordering of the nine compounds based 
on the fraction of 15N excreted (W=O.83, 
P < 0.01). All of the other 15N parameters 
except alanine also showed high intersubject 
consistency among subjects (table 1). As ex-
pected, parameters reflecting unlabeled 
nitrogen, such as nitrogen excretion and the 
BUN showed poor intersubject consistency 
(W < 0.35) . 
3) There was significantly less transfer-
ence of 15N from guanido-labeled arginine 
TABLE 1 
Summary of synthesis rates calculated by flux (PSR F) and cumulative excretion (PSR T) methods and 
ISN enrichment of the urinary ammonia, hippuric acid and plasma alanine' 
Urine Urine Plasma 
hippuric ammonia alanine 
PSRT PSRF acid '5N UN '5N 
g, protein kg per d APE 
Arginine 2.4 ± 0.7" 27.6 ± 7.5" 0.05 ± 0.02' 0.06 ± 0.01' 0.67 ± 0.I5b.
c 
Serine 4.4 ± 0.6"·b 6.6 ± 4.5b.c 2.03 ± 0.26b 0.26 ± 0.06b 0.71 ± 0.29,·b 
Glycine 4.3 ± 1.0,·b 5.2 ± 1. 9c•d 1.93 ± 0.31b 0.23 ± 0.06b 1. 71 ± 0 .89' 
Asparagine 4.8 ± 2.1,·b 9.2 ± 2.2b 0.12 ± O.Olf 0.16 ± 0 .13c 0 .91 ± 0.69,·b 
NH.CI 7.2 ± 2.7b.c 13.2 ± 2.5' 0.26 ± 0.02d 0.11 ± 0.02c 0 .58 ± 0.08
c 
Glutamate 6.2 ± 1.2b 7.2 ± 1.9c•d 0.26 ± 0.04c.d 0.19 ± 0.03b 0.89 ± 0.10··b 
Aspartate 6.9 ± 1.9b.c 10.3 ± 4.5"·b 0.23 ± 0.02d •• 0.16 ± 0.05c 0.83 ± O.U ,·b 
Glutamine 9.4 ± 2.7C 5.1 ± 3.1d 0.17 ± 0.02' 0.25 ± 0 .05b ND 
Alanine 10.4 ± 3.3c 9.2 ± 2.4b 0 .35 ± 0.02c 0 .15 ± 0.03c 0 .99 ± 0.42" 
Mean 6.1 ± 0.9 10.4 ± 2.6 0.60 ± 0 .28 0.23 ± 0.05 1.07 ± 0.34 
W (P) 0 .79 (0.02) 0.72 (0.05) 0.97 (0 .01) 0.84 (0.01) 0.42 (NS) 
I Values are means ± SEM. ND, no data. Unlike superscripts differ by P<0.05. APE is atom percent excess (ION) . 
W is the Kendall coefficient of concordance (20) . 
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to ammonia or hippuric acid than from any 
other compound (table 1). 
4) Two of the subjects excreted a very 
large proportion of the guanido N from ar-
ginine as urea (48 and 44 % vs. 23 and 21 % ). 
5) Less 15N from alanine and glutamine 
were excreted than from any of the other 
compounds tested (fig. 1). 
6) Reasonable urinary ammonia 15N 
plateaus were obtained for the nine com-
pounds (figure 2). 
7) There was no close relationship be-
tween the protein synthesis rate based on the 
urinary ammonia ISN enrichment (PSRF) 
and the value derived from the total amount 
of 15N excreted (PSRT). 
DISCUSSION 
Selection oj study conditions. The normal 
dietary intake between 0700 and 1700 of the 
four subjects ranged from breakfast (toast 
and coffee) and a meal for lunch to black 
coffee only. The dietary regimen (50 kcallh) 
of Ensure was a compromise designed to ap-
proximate the mean normal nutritional in-
take of the four subjects for that period. 
During the study, the subjects performed 
their normal daily duties. 
As a proportion of the oral diet given, the 
test amino acid may have represented up to 
a 50 % increase in the dietary amount of the 
test amino acid. Such relatively high 
dosages are routinely used in stable isotope 
tracer studies because of the relatively high 
enrichment levels needed for detection with 
most currently available analytical equip-
ment (9). The "tracer" amino acid is mixed 
with the much larger pool of amino acids 
derived from protein breakdown so that the 
contribution to the amino acid flux ap-
proaches a tracer dose ( - 5 %; refs. 9, 18, 19, 
21) . 
Excretion oj 15N. There was high inter-
subject reliability in the ordering of amino 
acids based on the fraction of 15N excreted 
(W=0.83, P>O.Ol). Furthermore, the com-
pounds tested appeared to fall into five well-
defined groups (fig. 1): 1) arginine, 2) serine 
and glycine, 3) asparagine and ammonia, 4) 
glutamate and aspartate and 5) glutamine 
and alanine (fig. 1). These groupings corre-
spond to 1) an amino acid which is a very 
close precursor of urea (arginine), 2) amino 
acids which are interconvertible and metabo-
lized via ammonia and one carbon transfer 
reactions (serine and glycine), 3) com-
pounds that are metabolized as ammonia 
(NH4Cl and asparagine, which is hydro-
lyzed to ammonia in the gut), 4) amino 
acids whose carbon skeletons play key roles 
in intermediary metabolism (aspartate and 
glutamate) and 5) dual-function amino 
acids where the carbon skeleton is involved 
in intermediary metabolism and interorgan 
nitrogen transport (glutamine and alanine). 
Although it was expected that a large 
proportion of the nitrogen from arginine 
would be metabolized to urea, the magni-
tude in two of our four subjects was surpris-
ing (48 and 44 % vs. 21 and 23 %). This may 
be due to human variability (22). Arginine 
has been reported to be a marginally essen-
tial amino acid (23). 
Transjerence oj 15N to other nonessential 
amino compounds. A high degree of con-
sistency across subjects in the ordering of 
amino acids was found for the 15N enrich-
ment of urinary ammonia and hippuric acid 
but not for alanine (table 1), possibly be-
cause of the lower sensitivity of the GC-MS 
analysis (±0.2 atom percent excess). Like 
the alanine and hippuric acid 15N enrich-
ment, the urinary enrichment of ammonia 
is another indicator of 15N transference but 
reflects both the enrichment of the free 
amino acid pools and the proportion of am-
monia derived from the carrier amino acid. 
No other amino acid transferred signifi-
cantly more ISN to urinary ammonia or 
plasma than glycine (table 1). 
Calculation oj protein synthesis rates. 
Although all estimates of the human body 
protein synthesis rate are based on the three-
pool compartmental model developed by San 
Pietro and Rittenberg (5), there are many 
variants, each of which is based on slightly 
different sets of assumptions (18, 19, 24, 25). 
From all of these methods a consensus has 
emerged that the daytime human whole-
body PSR is in the range of 1.5 to 6 g pro-
tein/kg per d. In this study we obtained val-
ues from the urinary ammonia plateau ISN 
enrichment and from total amount of ISN ex-
creted. There was no apparent relationship 
between the whole-body PSR values derived 
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Fig. 2 Urinary ammonia enrichments for the urine specimens collected between 1230 and 1700. Data not 
normalized. 
from the urinary ammonia and total excre-
tion of 15N. 
Cumulative 15N excretion. The basic as-
sumption underlying the end point ap-
proach is that administered 15N is parti-
tioned between end product (urea) and 
protein in the same proportion as total 
nitrogen, most of which is derived from en-
dogenous protein breakdown. Although this 
issue has been addressed by several authors 
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previously, it is still not resolved fo r lSN (7, 
8, 13). The partitioning coefficient, or syn-
thesis rates derived therefrom, should be in-
dependent of the route of isotope adminis-
tration. Unless they are, one or both routes 
of isotope administration cannot reflect the 
composite endogenous nitrogen metabo-
lism. Thus this study yields data on two 
criteria: 1) the calculated PSR should be in 
reasonable agreement with the value de-
rived by other (carbon-labeled) methods, 
and 2) there should be reasonable agreement 
between the intravenous and orally derived 
values . 
Most of the PSRs calculated by the cu-
mulative excretion method in the present 
study are w ithin the "consensus range" of l.5 
to 6 g protein/kg per d. The oral values 
found for glutamine and alanine (10.4 and 
9.4 g protein/kg per d) in this study were 
high, although rates within the "consensus 
range" have been reported with the in-
travenous route (2.8 and 3.6 g protein/kg per 
day) , respectively (10, 24) . The oral aspar-
tate and glutamate values are also elevated 
(table 1). These four amino acids are, as 
pointed out above, dual-function amino 
acids, and the second function can affect the 
partitioning of nitrogen. Previously, Tarunga 
(26) reported that essential amino acid 
nitrogen was unsuitable as a tracer because 
the nitrogen metabolism reflected the 
metabolism of the carbon skeleton. This 
study extends that conclusion to nonessen-
tial amino acids where the metabolism of 
the amino acid is dependent On both the 
partitioning between synthesis and excre-
tion and the role in intermediary metabo-
lism of the deaminated amino acid. Glycine 
meets the criteria of having no other major 
metabolic role if serine is regarded as part of 
the glycine pool. Glycine gives the same 
values orally or intravenously (25). 
Urinary ammonia. There are at least two 
routes by which lsN can be transferred to 
ammonia and then excreted in the urine. 
One is by entering, mixing and equilibrat-
ing with the body's free amino acid pools, a 
key assumption of both the flux and end 
product approaches. The other is by serving 
as a precursor to urinary ammonia without 
having attained isotopic equilibration in the 
tissue free amino acid pools. Different 
amino acids contribute differently to the 
urinary ammonia, although the major 
precursor is plasma glutamine, and this may 
explain the lack of correlation between the 
methods (table 1, ref. 24). The values de-
rived for the two methods were more similar 
for glycine than for any other lsN compound 
tested. 
The cumulative excretion method is much 
less dependent On the urinary ammonia en-
richment because more than 90 % of the lsN 
is excreted as urea. These uncertainties, the 
lack of correlation with the more theoreti-
cally sound total-excretion-based values and 
the range and scatter in the flux-based 
values suggest that the cumulative excretion 
of total lsN is the preferable approach. 
Use oj 15N-labeled nonessential amino 
acids as tracers. There is some question as to 
how widely applicable single-isotope whole-
body methods are. Anomalously high PSRs 
have been reported with glycine (8, 27), 
tyrosine (28) and leucine (29) in situations 
where there was hepatic insufficiency. The 
liver is particularly important in the mixing 
and equilibrating processes. Unexpectedly 
low (negative values) have been found with 
[1-13C]leucine in human subjects on low pro-
tein diets and during a simulated triathlon 
(30, 31) . The fact that apparently anomalous 
results are found with several tracers suggests 
that the effect is not specific to the amino acid 
used but a failure of the model where liver 
insufficiency or other serious perturbations 
may result in compartmentation of the tis-
sue free amino acid pools (27). The presence 
of any of these situations limits the applica-
bility of single-isotope whole-body methods 
for the measurement of human whole-body 
protein synthesis rates . 
The use oj rWJglycine. The PSR values de-
rived from the two methods used in this 
study were closer for glycine than for any other 
amino acid and are similar to those found 
with 13C-Iabeled amino acids. No other 
nonessential lsN-Iabeled amino acid has 
been shown to be superior to glycine. 
[15N]glycine has several distinct advantages 
for studying human protein metabolism: 1) 
Methods involving [lSN]glycine are techni-
cally the simplest (e.g., single-point assays 
(2) ; 2) [lSN]Glycine is relatively cheap and 
readily available in a pure state; 3) More is 
r- . I R . 
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known about the metabolism of [15N]glycine 
than any other 15N-Iabeled amino acid; 4) 
Only [lSN]glycine offers the possibility of 
simultaneously measuring liver-originated 
plasma protein synthesis rates by using the 
urinary hippuric acid to determine the en-
richment of the liver intracellular glycine 
pool (16). 
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